Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06294938
Other study ID # M.WRI-2023-INQ-2224
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 30, 2022
Est. completion date May 23, 2023

Study information

Verified date March 2024
Source Mars Wrigley
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cacao fruit pulp is a sweet and fruity carbohydrate-rich edible mucilage that is often discarded. The objective of this study is to assess the glycemic response and determine the glycemic index of cacao fruit pulp.


Description:

In an acute, open-labeled, randomized design, individuals without diabetes were studied over 120 minutes after consuming 25 grams of available carbohydrate portions of cacao pulp or dextrose.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date May 23, 2023
Est. primary completion date January 24, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: Subjects were males or non-pregnant females and in good health. Exclusion Criteria: Subjects with a known history of AIDS, hepatitis, diabetes or a heart condition. Subjects taking medication or with any condition that might make participation dangerous to the subject, to others, or affect the results.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cacao fruit pulp
Cacao pulp puree
Dextrose
Dextrose beverage

Locations

Country Name City State
Canada INQUIS Clinical Research Toronto Onterio

Sponsors (2)

Lead Sponsor Collaborator
Mars Wrigley INQUIS Clinical Research

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Plasma Glucose Mean plasma glucose 1-120 minutes
Primary Incremental area under the curve Calculated from mean plasma glucose 1-120 minutes
Primary Peak plasma glucose Peak plasma glucose (Cmax) 1-120 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06000735 - Daily Blood Glucose Trends in Patients at Risk for Diabetes N/A
Completed NCT06146322 - Barley Beta-glucan, Glycemic Control, and Appetite N/A
Completed NCT05658757 - Preliminary Effect of Food Processing and Sweeteners on Glycemic and Metabolic Measures N/A
Not yet recruiting NCT05851040 - Observe the Effect of Wheatgrass and Tulsi Formulation or Individuals Taken With Other Allopathic Drugs
Completed NCT04051294 - The Effect of Kombucha on Blood Sugar Levels in Humans N/A
Active, not recruiting NCT06333496 - Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans N/A
Active, not recruiting NCT06150495 - Glycemic Control and Retinal Microvascular Changes
Completed NCT05349916 - The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans N/A
Completed NCT03529344 - A Study on the Effects on Glucose Regulation, Inflammation and Serum Lipids After Fish Protein Supplementation in Elderly (GRIPE) N/A
Recruiting NCT05365152 - The Effect of Meal Replacement on the Time to Reach the Blood Glucose Target in Patients With Type 2 Diabetes Mellitus N/A